Human studies, particularly in the pediatric population, found that children with migraine had significantly higher serum levels of IL-17A compared to healthy controls, even outside the crisis, and that these levels were associated with an increased risk of migraine (OR ≈ 1.07 per increment, p = 0.01). This evidence concerns the gene IL17A and migraine disorder.